D.A. DAVIDSON & CO. - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 207 filers reported holding NEKTAR THERAPEUTICS in Q1 2017. The put-call ratio across all filers is 0.37 and the average weighting 0.2%.

Quarter-by-quarter ownership
D.A. DAVIDSON & CO. ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q3 2018$280,000
+24.4%
4,6000.0%0.01%
+25.0%
Q2 2018$225,000
-54.0%
4,6000.0%0.00%
-60.0%
Q1 2018$489,000
+77.8%
4,6000.0%0.01%
+66.7%
Q4 2017$275,000
+209.0%
4,6000.0%0.01%
+200.0%
Q2 2017$89,000
-16.8%
4,6000.0%0.00%
-33.3%
Q1 2017$107,000
+57.4%
4,600
-17.9%
0.00%
+50.0%
Q4 2016$68,000
-29.2%
5,6000.0%0.00%0.0%
Q3 2016$96,000
+11.6%
5,600
-8.2%
0.00%
-33.3%
Q2 2016$86,000
+1333.3%
6,100
+1120.0%
0.00%
Q1 2016$6,000
-25.0%
5000.0%0.00%
Q4 2015$8,0005000.00%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q1 2017
NameSharesValueWeighting ↓
Strong Tower Advisory Services 404,972$6,913,0004.02%
GREAT POINT PARTNERS LLC 504,691$9,064,0002.11%
Camber Capital Management LP 3,750,000$67,350,0002.07%
ACT CAPITAL MANAGEMENT, LLC 161,500$2,901,0001.50%
Rhenman & Partners Asset Management AB 950,000$17,062,0001.20%
MAVERICK CAPITAL LTD 5,838,426$104,858,0001.06%
Birchview Capital, LP 72,000$1,293,0000.88%
Bellevue Group AG 4,594,656$82,519,0000.84%
CM Management, LLC 50,000$898,0000.67%
Duquesne Family Office 1,000,000$17,960,0000.58%
View complete list of NEKTAR THERAPEUTICS shareholders